Emerging Strategies for Therapeutic Antibody Discovery from Human B Cells

Area of Science:

• Immunology
• Biotechnology
• Therapeutic Antibody Development

Background:

• Human monoclonal antibodies are valuable therapeutics due to specificity, potency, and safety.
• Challenges in discovery include rarity and short lifespan of B cells ex vivo.
• Maintaining variable heavy (V_H) and variable light (V_L) domain pairing is crucial for antibody function and a throughput limitation.

Purpose of the Study:

• To review current approaches for discovering human monoclonal antibodies.
• To highlight challenges associated with B cell isolation and antibody chain pairing.
• To discuss next-generation methods for high-throughput discovery from the human B-cell repertoire.

Main Methods:

• Review of existing literature on human B cell repertoire analysis.
• Discussion of techniques for isolating and culturing antibody-producing B cells.
• Examination of strategies for preserving V_H-V_L domain integrity during discovery.

Main Results:

• Existing methods face limitations in efficiency and throughput.
• Next-generation approaches aim to address B cell rarity and ex vivo stability.
• Techniques for maintaining antibody chain pairing are critical for successful discovery.

Conclusions:

• Overcoming challenges in human antibody discovery is essential for advancing therapeutics.
• High-throughput methods are needed to fully exploit the human B cell repertoire.
• Continued innovation in discovery platforms will enhance the development of novel human monoclonal antibodies.